|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/397 | (2006.01) |
| A61K 9/00 | (2006.01) | ||
| A61K 31/431 | (2006.01) | ||
| A61K 31/546 | (2006.01) | ||
| A61P 31/04 | (2006.01) |
| (11) | Number of the document | 3616695 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19203616.8 |
| Date of filing the European patent application | 2012-09-07 | |
| (97) | Date of publication of the European application | 2020-03-04 |
| (45) | Date of publication and mention of the grant of the patent | 2024-10-23 |
| (46) | Date of publication of the claims translation | 2024-11-25 |
| (30) | Number | Date | Country code |
| 201161532914 P | 2011-09-09 | US | |
| 201261657386 P | 2012-06-08 | US |
| (72) |
CHANDORKAR, Gurudatt, A. , US
HUNTINGTON, Jennifer, A. , US
PARSONS, Tara , US
UMEH, Obiamiwe, C. , US
|
| (73) |
Merck Sharp & Dohme LLC ,
126 East Lincoln Avenue, Rahway, New Jersey 07065,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Ceftolozanas/ tazobaktamas, skirti plaučių infekcijoms gydyti |
| CEFTOLOZANE/TAZOBACTAM FOR TREATING INTRAPULMONARY INFECTIONS |
| Payment date | Validity (years) | Amount | |
| 2025-08-25 | 14 | 289.00 EUR |
| 2026-09-07 |